Generics 51

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cilnidipine manufacturers

51 products found

Filters

51 products found

cilnidipine + telmisartan

Tablets 10 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

cilnidipine

Tablets 5 mg, 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

cilnidipine

Tablets 10 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19850

Manufacturer usually replies in 2 days

cilnidipine + nebivolol

Tablets 10 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

cilnidipine + olmesartan medoxomil + chlortalidone

Tablets 10 mg + 20 mg + 6.25 mg, 10 mg + 20 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

cilnidipine + telmisartan + chlortalidone

Tablets 10 mg + 40 mg + 6.25 mg, 10 mg + 40 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

cilnidipine + chlortalidone

Tablets 10 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

cilnidipine + telmisartan

Tablets 10 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17798

Manufacturer usually replies in 4 days

cilnidipine

Tablets 5 mg, 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

cilnidipine + telmisartan

Tablets 10 mg+40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19508

Manufacturer usually replies in 9 days

cilnidipine

Tablets 5 mg, 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19508

Manufacturer usually replies in 9 days

cilnidipine + metoprolol

Tablets 10 mg+50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19203

Manufacturer usually replies in 6 days

cilnidipine + telmisartan

Tablets 10 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212

Manufacturer usually replies in 10 days

cilnidipine + metoprolol succinate

Tablets, extended release (ER) 10 mg + 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212

Manufacturer usually replies in 10 days

cilnidipine + olmesartan + chlortalidone

Tablets 10 mg + 20 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212

Manufacturer usually replies in 10 days

cilnidipine + chlortalidone

Tablets 10 mg + 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212

Manufacturer usually replies in 10 days

cilnidipine

Tablets 5 mg, 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18212

Manufacturer usually replies in 10 days

cilnidipine + chlortalidone + telmisartan

Tablets 5 mg + 12.5 mg + 40 mg, 10 mg + 12.5 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18136

Manufacturer usually replies in 8 days

cilnidipine

Tablets 5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18136

Manufacturer usually replies in 8 days

cilnidipine

Tablets 5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

Want to view all 51 products? Create your free account today!

Cilnidipine:

Cilnidipine is a calcium channel blocker and is used as a medication in the treatment of hypertension. It was originally jointly developed by Fuji Viscera Pharmaceutical Company and Japan Ajinomoto in Japan and was subsequently approved for commercial sale in the medical marketplace in 1995. Currently, it has found both widespread use and regulatory approval. Being approved for sale in influential markets such as China, Japan, Korea, India, and the European Union. As such, it is produced for sale by many cilnidipine manufacturers and cilnidipine suppliers across the global marketplace. And is commonly found available to order on the pharmaceutical products list of global distributors, where it can be purchased wholesale at a variety of cost and price points.

Method of action of Cilnidipine:

Cilnidipine belongs to a group of drugs which function as calcium ion channel blockers. Specifically, cilnidipine binds and inhibits the L-type calcium channels of blood vessels, blocking calcium ion flow and subsequently suppressing the contraction of blood vessels, allowing for vessel dilation which serves to reduce blood pressure. Additionally, cilnidipine also targets N-type calcium channel situated at the terminus of the sympathetic nerve, this causes the inhibition of norepinephrine and surpasses the increase in stress-mediated blood pressure rise.

Form and dosage of Cilnidipine:

The final form and packaging are dependent on manufacturers and suppliers, as well as the specific distributors and order. However, cilnidipine typically is on the wholesale list in forms including tablets and film-coated tablets. The recommended dose of cilnidipine for adults is 5 – 10 mg taken once daily. With the maximum dose strongly recommended to not exceed 20 mg per day. Cilnidipine is unsuitable for patients with acute unstable angina, cardiogenic shock, severe aortic stenosis, or have suffered a recent heart attack. For further information please refer to the manufacturers’ instructions or contact an accredited medical professional.

Cilnidipine on Pipelinepharma:

Currently, at the time of writing, we have found 2 verified cilnidipine manufacturers and cilnidipine suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including South Korea and Bangladesh. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of Cilnidipine and how to buy:

A cursory search online reveals an approximate wholesale cost for cilnidipine to be USD 0.68 for 10 mg x 10 tablets exported from India. This indicated value is not intended as a definite guide, as the specific cost of any pharmaceutical purchase will be highly dependent on the individual circumstance. As such, the indicated value solely serves as a generalization of the current market pricing. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.